ABVC BioPharma, Inc. (NASDAQ:ABVC) shares are trading higher on Monday after the company appointed Uttam Yashwant Patil as the new Chief Executive Officer.
Patil has served as the Chief Operating Officer & Chief Scientific Officer of BioKey, Inc., a GMP-certified facility owned by ABVC.
“Dr. Uttam has exceptional strategic capabilities, an international network, proven operational effectiveness, and strong background in fundraising,” ABVC Board said.
He is also the R&D Manager for an ABVC collaborative program on new plant-based drugs and combination cancer therapies. This experience gives ABVC “solid leadership in plant-based therapeutics.”
Patil’s employment with ABVC began on June 23, 2023.
“The Board looks forward to realizing his potential in delivering long-term growth and value for all its stakeholders.”
Price Action: ABVC shares are trading higher by 7.7% to $0.57 on the last check Monday.
